TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $21.9K2012: $1.77M2013: $3.52M2014: $25.56M2015: $22.47M2016: $8.50M2017: $1.71M2018: $2.43M2019: $36.28M2020: $2.50M2021: $44.44M2022: $5.40M2023: $4.09M2024: $3.86M2025: $3.50M$3.50M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.50M-9.3%
2024$3.86M-5.7%
2023$4.09M-24.2%
2022$5.40M-87.9%
2021$44.44M+1681.0%
2020$2.50M-93.1%
2019$36.28M+1394.9%
2018$2.43M+41.9%
2017$1.71M-79.9%
2016$8.50M-62.2%
2015$22.47M-12.1%
2014$25.56M+625.8%
2013$3.52M+98.7%
2012$1.77M+8006.6%
2011$21.9K—